Tests a home stimulation suit for muscle stiffness and poor coordination in multiple sclerosis
Tests a full-body stimulation suit worn at home by adults with multiple sclerosis.
Plain-language title generated from the registry record
Registry title: At Home Use of Stimulation Suits for Managing MS Symptoms
Key facts
- Where
- Steenokkerzeel, BelgiumSee the site
Where in Belgium
- Nationaal MS Center MelsbroekSteenokkerzeel, BelgiumTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Daphne Kos
- Trial code
- NCT07202195
- Record updated
- 8 October 2026
- Original description
This study is being carried out at Multiple Sclerosis (MS) centers to evaluate whether a full-body stimulation suit at home can help people with Multiple Sclerosis (pwMS) reduce symptoms like spasticity (muscle stiffness) and ataxia (poor coordination), and improve daily functioning.Read full original descriptionShow less
Home-Based Neuromodulation Suits for Reducing Spasticity and Ataxia in Multiple Sclerosis: A Multi-center RCT
This study is being carried out at Multiple Sclerosis (MS) centers to evaluate whether a full-body stimulation suit at home can help people with Multiple Sclerosis (pwMS) reduce symptoms like spasticity (muscle stiffness) and ataxia (poor coordination), and improve daily functioning.
Can pwMS who experience spasticity or ataxia benefit from using a stimulation suit for 6 weeks?
Researchers will compare two groups: an intervention group (who will use the suit) and a control group (who will not use the suit).
Participants in the intervention group will:
* Wear the suit for 6 weeks in total every day or every other day (1 week during their MS center admission and 5 weeks at home). * Receive their usual care in addition to wearing the suit. * Undergo clinical tests at the MS center after 1 week and 6 weeks of stimulation.
Participants in the control group will:
* Receive their usual care. * Undergo clincial tests at the same time points as the other group.
Inclusion: Eligible participants must have ataxia or spasticity alongside impairments in upper or lower extremity physical function. MAS score ≥ 1 will be used as an inclusion criterion to determine the presence of spasticity. SARA score ≥ 4 will be used as an inclusion criterion to determine the presence of ataxia. Note: one of the two criteria (MAS score or SARA score) must be fulfilled for a pwMS to be eligible; The patient must have the cognitive abilities to understand instructions and to be able to complete the questionnaires adequately; Diagnosis of multiple sclerosis.
Exclusion: Change in disease modifying treatment within the last 3 months; Skin eruptions and/or skin areas in the stimulation zone that are swollen, infected or inflamed; Implanted devices (like pacemaker, Baclofen pump, neurostimulator, defibrillator, shunts, ECG equipment, electronic life support, high frequency operation equipment ); Use of Botuline Toxine A within the last 3months; Recent relapse within the last 3 months; Acute musculoskeletal problems that hinder the test performance,; Pregnancy; Sizes bigger than 3XL (triple eXtra Large).